153 related items for PubMed ID: 26222760
1. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A.
Pediatr Int; 2016 Mar; 58(3):180-184. PubMed ID: 26222760
[Abstract] [Full Text] [Related]
2. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Mar; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
3. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
4. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
Kimura M, Harazaki M, Fukuoka T, Asakura I, Sakai H, Kamimaki T, Ohkawara I, Akiyama N, Tsurui S, Iwashima S, Shimomura M, Morishita H, Meguro T, Seto S.
Pediatr Int; 2017 Apr; 59(4):397-403. PubMed ID: 27743415
[Abstract] [Full Text] [Related]
5. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
[Abstract] [Full Text] [Related]
6. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
Hashimoto I.
Pediatr Int; 2019 Jul; 61(7):641-646. PubMed ID: 31132210
[Abstract] [Full Text] [Related]
7. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Jul; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
8. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Jul; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
9. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T.
Cochrane Database Syst Rev; 2023 Jan 25; 1(1):CD014884. PubMed ID: 36695415
[Abstract] [Full Text] [Related]
10. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
Acta Paediatr; 2010 Oct 25; 99(10):1578-83. PubMed ID: 20491705
[Abstract] [Full Text] [Related]
11. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
Arch Dis Child; 2011 Nov 25; 96(11):1088-90. PubMed ID: 20551193
[Abstract] [Full Text] [Related]
12. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 25; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
13. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 25; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
14. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
Int J Clin Pract; 2022 May 25; 2022():2726686. PubMed ID: 35989868
[Abstract] [Full Text] [Related]
15. Targeted Use of Prednisolone with Intravenous Immunoglobulin for Kawasaki Disease.
Sakai H, Iwashima S, Sano S, Akiyama N, Nagata E, Harazaki M, Fukuoka T.
Clin Drug Investig; 2021 Jan 25; 41(1):77-88. PubMed ID: 33341911
[Abstract] [Full Text] [Related]
16. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 25; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
17. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
[Abstract] [Full Text] [Related]
18. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
Tanaka A, Inoue M, Hoshina T, Koga H.
J Pediatr; 2021 Sep 25; 236():95-100. PubMed ID: 34019881
[Abstract] [Full Text] [Related]
19. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
[Abstract] [Full Text] [Related]
20. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T, Kato I, Shiohama T, Abe K, Anzai S, Takeda N, Yamaguchi KI, Kanazawa M, Kurosaki T.
Pediatr Int; 2011 Oct 12; 53(5):729-735. PubMed ID: 21342358
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
